The influence of serum sodium concentration on prognosis in resected non-small cell lung cancer

Thorac Cardiovasc Surg. 2014 Jun;62(4):338-43. doi: 10.1055/s-0033-1359713. Epub 2013 Dec 2.

Abstract

Background: Hyponatremia is the most common electrolyte disorder and is a negative prognostic factor in several kinds of cancer. However, few reports have referred to hyponatremia in non-small cell lung cancer (NSCLC). In the present study, the authors examined the influence of preoperative serum sodium concentration on survival in completely resected NSCLC.

Methods: A total of 386 completely resected NSCLC patients were retrospectively analyzed.

Results: Kaplan-Meier survival curves showed that serum sodium concentration was a significant prognostic factor, and the log-rank statistical value was maximum (9.173, p = 0.002) when the cutoff value of serum sodium concentration was 139 mEq/L. The overall 5-year survival rate of the high-serum sodium concentration group (> 139 mEq/L) was 74.8% and that of the low-serum sodium concentration group (≤ 139 mEq/L) was 59.7%. Clinicopathological factors showed significant differences between the two groups for leukocyte count, neutrophil count, C-reactive protein, tumor size, and pleural invasion.

Conclusions: Low-serum sodium concentration, which was associated with tumor status and inflammation, had negative prognostic influence in completely resected NSCLC.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Carcinoma, Non-Small-Cell Lung / complications
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Chi-Square Distribution
  • Female
  • Humans
  • Hyponatremia / blood
  • Hyponatremia / complications*
  • Hyponatremia / diagnosis
  • Hyponatremia / mortality
  • Kaplan-Meier Estimate
  • Lung Neoplasms / complications
  • Lung Neoplasms / mortality
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Pneumonectomy* / adverse effects
  • Pneumonectomy* / mortality
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Sodium / blood*
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Sodium